Integration of Novel Management Strategies for Metastatic Castration Resistant Prostate Cancer - Philadelphia, PA
Hematology-OncologyProstate Cancer
1 ACPE 1 CA-BRN Credit(s) 1 AMA PRA Category 1 Credit(s) ™
November 20, 2013
The accreditation for this activity has expired.
Primary Audience:
Physicians, Nurses and Pharmacists
Relevant Terms:
Oncology, Oncology Nursing, Oncology Pharmacy, Prostate, Prostate Cancer
Daniel Petrylak, MD
Daniel Petrylak, MD
Professor of Medicine, Medical Oncology
Director, Prostate and GU Medical Oncology
Director, Prostate Cancer Translational Research Group
Yale Cancer Center
New Haven, CT
Bio
| 1. | Describe therapeutic options with existing agents for patients with castration-resistant prostate cancer and how to manage therapy for individual patients. | 2. | Apply recent data with emerging therapies for the treatment of patients with castration-resistant prostate cancer and integrate key findings into clinical practice. |
| 1. | Describe therapeutic options with existing agents for patients with castration-resistant prostate cancer and how to manage therapy for individual patients. |
| 2. | Apply recent data with emerging therapies for the treatment of patients with castration-resistant prostate cancer and integrate key findings into clinical practice. |
Medical Learning Institute Peer Review
William Wong, MD
Peer Reviewer
Medical Learning Institute, Inc.
Patricia Ensor, RPh, MBA
Peer Reviewer
Medical Learning Institute, Inc.
Pamela Vlahakis, RN, MSN, CBCN
Peer Reviewer
Medical Learning Institute, Inc.
Physician Credit Designation
The Medical Learning Institute Inc designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Medical Learning Institute Inc and the Center of Excellence Media, LLC. The Medical Learning Institute Inc is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Registered Nurse Designation
Medical Learning Institute Inc
Provider approved by the California Board of Registered Nursing, Provider Number 15106, for 1.0 contact hour.
Registered Pharmacy Designation
The Medical Learning Institute Inc is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Completion of this application-based activity provides for 1.0 contact hour (0.1 CEU) of continuing pharmacy education credit.
The Universal Activity Number for this activity is 0468-0000-13-018-L01-P.
Purpose Statement
The purpose of this activity is to measure changes in performance of physicians, nurses, and pharmacists concerning the treatment of mCRPC.
Commercial Support Acknowledgment
This activity is supported by educational grants from AbbVie, Bayer and Dendreon.
Sponsor
This activity is jointly sponsored by Medical Learning Institute Inc and Center of Excellence Media, LLC.
Disclaimer
The information provided at this CME/CPE/CE activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient's medical condition.
Recommendations for the use of particular therapeutic agents are based on the best available scientific evidence and current clinical guidelines. No bias towards or promotion for any agent discussed in this program should be inferred.
Disclosure
Before the activity, all faculty and anyone who is in a position to have control over the content of this activity and their spouse/life partner will disclose the existence of any financial interest and/or relationship(s) they might have with any commercial interest producing healthcare goods/services to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speakers bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions. All identified conflicts of interest are thoroughly vetted by Medical Learning Institute Inc for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
The associates of Medical Learning Institute Inc, the accredited provider for this activity, and Center of Excellence Media, LLC, does not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this CME/CPE/CE activity for any amount during the past 12 months.
Instructions for Credit
There is no fee for this activity. To receive credit for this CME/CPE/CE activity, please take a few minutes to complete the pre-survey, evaluation form, & post-test. Your certificate of credit will be e-mailed to you immediately.
For questions regarding the accreditation of this activity, please contact Medical Learning Institute Inc at (609) 333-1693 or cgusack@mlicme.org.
For pharmacists, Medical Learning Institute Inc will report your participation in this educational activity to the NABP only if you provide your NABP e-Profile number and date of birth. For more information regarding this process or to get your NABP e-Profile number: go to www.mycpemonitor.net.
COURSE VIEWING REQUIREMENTS
| Supported Browsers: Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8 Google Chrome 18.0+ for Windows, Mac OS, or Linux Mozilla Firefox 13.0+ for Windows, Mac OS, or Linux Safari 4.0+ for Mac OSX 10.5 and above | Supported Phones & Tablets: Android 4.0.3 and above iPhone/iPad with iOS 6.1 or above |
